Resources

A pipeline of encouraging funding opportunities for the engineering biology community

New AI infrastructure, the MHRA AI Sandbox, life science leadership, global advocacy and BIA’s upcoming events

Pelago Bioscience has acquired RG Discovery. As a result of this acquisition, the largest Scandinavian CRO specializing in drug discovery has been created.

Explore Columbus Global's latest life science report featuring expert into the digital trends shaping the future of Pharma, MedTech and Biotech in 2026 and beyond

The challenge of converting scientific progress into real-world access

Autolus Therapeutics today announced that the Galien Foundation has presented the Company with the 2026 Prix Galien UK Award for Best Biotechnology Product.

How finance leaders can manage R&D tax risk while supporting innovation investment

Poolbeg Pharma announces new research on two posters, by Poolbeg and The University of Manchester respectively, are being presented at the European Hematology Association Congress.

Poolbeg Pharma, a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces the first site activation for the first-in-patient POLB 001 TOPICAL* clinical trial has occurred.

Discovery Park, Kent’s science and innovation hub, has launched the seventh edition of its Discovery Spark accelerator programme, welcoming 12 startups to its campus in Sandwich.

New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing.

Grant awarded through the Parkinson's Disease Therapeutics Pipeline Program to support advancement of Harness' new programme targeting GCase and LIMP2 for Parkinson's disease.

Chris Molloy on building on Parliament Day's momentum, TechBio's breakthrough week, the Oxford-to-Cambridge expansion, and driving global investor confidence at the Leadership Summit

Driven by world-class science and monumental funding, the UK TechBio sector is undergoing a profound paradigm shift –​​​​​​​​​​​ meet the innovative BIA members leading the charge

Engitix announced a strategic research collaboration and option agreement with GSK to identify and validate novel therapeutic targets driving liver fibrosis regression.

Each month, our Policy and Public Affairs team will showcase how we are championing members’ voices in Government and Parliament.

BIA members gathered in London on Tuesday for our 26th annual Parliament Day

New strategic collaboration aims to overcome long‑standing barriers in brain‑targeted drug discovery

PrecisionLife, a leader in AI-driven precision medicine for chronic diseases, today announced the appointments of Dr Pradip Banerjee, PhD, MBA, as an Independent Non-Executive Director and Dr Kam Pooni, PhD, as Chief Product Officer. These strategic hires further strengthen the company’s leadership as it scales from a pioneering technology innovator to a commercial organization delivering real-world healthcare impact.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search for Quibim and is pleased to announce the placement of Itta MacNevin as Chief Business Officer (CBO).